Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients.

Front Immunol · 2022 · PMC9379325 · PMID 35983042

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slightly increasing trendno p-value reported

Before the policy, the amount of total steroid intake after the administration of rituximab until reaching PRMT and for six months afterward showed a slightly increasing trend, but not a significant one (total steroid intake until PRMT: β = 7.11, p = 0.380; total steroid intake over six months β = 3.38, p = 0.594).

also in 801 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.